116 related articles for article (PubMed ID: 16437336)
21. The treatment of anemia in peritoneal dialysis patients.
Lacson E; Diaz-Buxo JA
Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
[TBL] [Abstract][Full Text] [Related]
22. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
[TBL] [Abstract][Full Text] [Related]
23. [Peritoneal dialysis in patients with chronic kidney-graft failure].
Puttinger H
Wien Klin Wochenschr; 2005; 117 Suppl 6():35-9. PubMed ID: 16437331
[TBL] [Abstract][Full Text] [Related]
24. Darbepoetin alfa (KRN321) administered intravenously once monthly maintains hemoglobin levels in peritoneal dialysis patients.
Hiramatsu M; Kubota M; Iwasaki M; Akizawa T; Koshikawa S;
Ther Apher Dial; 2008 Feb; 12(1):19-27. PubMed ID: 18257808
[TBL] [Abstract][Full Text] [Related]
25. [Adequate peritoneal dialysis--new guidelines?].
Lilaj T
Wien Klin Wochenschr; 2005; 117 Suppl 6():83-8. PubMed ID: 16437338
[TBL] [Abstract][Full Text] [Related]
26. Randomized equivalence study evaluating the possibility of switching hemodialysis patients receiving subcutaneous human erythropoietin directly to intravenous darbepoetin alfa.
Chazot C; Terrat JC; Dumoulin A; Ang KS; Gassia JP; Chedid K; Maurice F; Canaud B;
Ann Pharmacother; 2009 Feb; 43(2):228-34. PubMed ID: 19407262
[TBL] [Abstract][Full Text] [Related]
27. [Iron therapy: is it different with peritoneal dialysis compared to haemodialysis?].
Durand PY
Nephrol Ther; 2006 Nov; 2 Suppl 5():S341-6. PubMed ID: 17373281
[TBL] [Abstract][Full Text] [Related]
28. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin use in peritoneal dialysis patients.
Zimmerman SW; Johnson CA
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
[TBL] [Abstract][Full Text] [Related]
30. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
Ahsan N
Adv Perit Dial; 1998; 14():228-31. PubMed ID: 10649730
[TBL] [Abstract][Full Text] [Related]
31. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
Daschner M; Mehls O; Schaefer F
Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
[TBL] [Abstract][Full Text] [Related]
32. [Anemia syndrome in patients with chronic renal insufficiency on peritoneal dialysis treated with recombinant erythropoietin].
Romanova LA; Lugovskaia SA; Khareb F; Shumov EV; Shmarov DA
Urologiia; 2002; (5):26-30. PubMed ID: 12402772
[TBL] [Abstract][Full Text] [Related]
33. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
34. [Peritoneal dialysis and cardiopulmonary comorbidity].
Wiesholzer M
Wien Klin Wochenschr; 2005; 117 Suppl 6():46-53. PubMed ID: 16437333
[TBL] [Abstract][Full Text] [Related]
35. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
[TBL] [Abstract][Full Text] [Related]
36. Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI.
Eschbach JW
Semin Nephrol; 2000 Jul; 20(4):320-9. PubMed ID: 10928333
[TBL] [Abstract][Full Text] [Related]
37. Iron dextran treatment in peritoneal dialysis patients on erythropoietin.
Suh H; Wadhwa NK
Adv Perit Dial; 1992; 8():464-6. PubMed ID: 1361849
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
39. [Changing the frequency of administration of darbepoetin alfa (from weekly to fortnightly) maintains the haemoglobin levels in patients undergoing peritoneal dialysis].
Bajo MA; Pérez Fontán M; Remón C; Sánchez-Tomero JA; Lladós F; Selgas R
Nefrologia; 2009; 29(2):136-42. PubMed ID: 19396319
[TBL] [Abstract][Full Text] [Related]
40. Management of renal anemia.
Peco-Antic A
Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]